DermaSensor Helps PCPs Differentiate Between Benign and Malignant Moles
DermaSensor can help clinicians more accurately differentiate between benign and malignant lesions, according to a new study in the Journal of the American Board of Family Medicine (JABFM). DermaSensor, a handheld AI-powered elastic scattering spectroscopy device, received U.S Food and Drug Administration (FDA) clearance in January 2024. This prospective study involved three primary care doctors in a rural […]